Bright Angel Therapeutics
Sean Liston is a skilled researcher with extensive experience in molecular and cellular biology, currently serving as a Postdoctoral Researcher at Bright Angel Therapeutics since December 2021. Responsibilities include antifungal susceptibility testing, development of biochemical assays for small molecule inhibitors, and writing standard operating procedures. Prior to this role, Sean Liston was a Postdoctoral Fellow at the University of Toronto from January 2018 to November 2021, where external funding was secured for research, mentorship was provided, and significant research on Candida albicans was conducted. Earlier experience as a Graduate Research Assistant at the University of Guelph involved protein and enzyme characterization, molecular biology techniques, and teaching assistance in analytical biochemistry and enzymology courses. Sean Liston holds a Ph.D. in Molecular and Cellular Biology and a B.Sc. in Biochemistry from the University of Guelph.
This person is not in the org chart
This person is not in any teams
Bright Angel Therapeutics
Bright Angel Therapeutics is a developer of novel therapeutics designed to provide treatment of drug-resistant and life-threatening fungal infections. The company's services increases efficacy of current treatments and eradicates drug resistance by targeting the stress responses required by fungi for survival, virulence and drug resistance,enabling users to overcome the frequent emergence of clinical resistance largely responsible for the severe morbidity and mortality associated with infection by diverse fungal pathogens.